Virtual Screening and Zebrafish Phenotype-Based Evaluation Argues Against Repurposing 4-Phenylbutyrate for STXBP1-Related Disorders.

However, following a Bonferroni correction for multiple comparisons, no drug significantly altered locomotion in either genotype, suggesting these nominally significant locomotion changes in WT larvae reflect ‘false positives’.

also in 7,732 other papers